REQUEST A DEMO
Total
USD $0.00
Search more companies

Sinofarm D.O.O. Stara Pazova (Serbia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Sinofarm D.O.O. Stara Pazova Profile Updated: October 13, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Sinofarm D.O.O. Stara Pazova is based in Serbia, with the head office in Stara Pazova. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. The enterprise was incorporated on October 04, 1993. Sinofarm D.O.O. Stara Pazova currently employs 30 (2019) people. From the latest financial highlights, Sinofarm D.O.O. Stara Pazova reported a net sales revenue increase of 23.88% in 2022. Its’ total assets recorded a growth of 15.06%. The net profit margin of Sinofarm D.O.O. Stara Pazova decreased by 8.68% in 2022.

Headquarters
Banovacka 34
Stara Pazova; Srem; Postal Code: 11000

Contact Details: Purchase the Sinofarm D.O.O. Stara Pazova report to view the information.

Website: http://www.sinofarm.co.rs

Basic Information
Total Employees:
Purchase the Sinofarm D.O.O. Stara Pazova report to view the information.
Outstanding Shares:
Purchase the Sinofarm D.O.O. Stara Pazova report to view the information.
Registered Capital:
Purchase the Sinofarm D.O.O. Stara Pazova report to view the information.
Incorporation Date:
October 04, 1993
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Sino Medwaste - U Likvidaciji
100%
Company Performance
Financial values in the chart are available after Sinofarm D.O.O. Stara Pazova report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RSD. Absolute financial data is included in the purchased report.
Net sales revenue
23.88%
Total operating revenue
46.18%
Operating profit (EBIT)
202.36%
EBITDA
184.46%
Net Profit (Loss) for the Period
-13.23%
Total assets
15.06%
Total equity
16.54%
Operating Profit Margin (ROS)
12.37%
Net Profit Margin
-8.68%
Return on Equity (ROE)
-5.08%
Debt to Equity Ratio
9.74%
Quick Ratio
0.07%
Cash Ratio
-0.17%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?